CVRF
Clinical Research Coordinating Center(CRCC)
Data Management
Core Laboratories
Translational Research
Research Activity
Paper Publication
Research Activity
  • Efficacy of the CYPHER SelectTM Sirolimus-Eluting Coronary Stent Implantation for Coronary Artery Stenosis
  • Randomized Comparison Study of CypherTM Stent Versus Brachytherpy for Treatment of Diffuse In-Stent Restenosis
  • The Effect of Sirolimus-Eluting Stent for Very Long Coronary Lesions
  • The Effect of Paclitaxel-Eluting Stent for Very Long Coronary Lesions
  • Randomized Comparison of Triple Versus Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation; Will There Be a Synergy of DES and Cilostazol in Restenosis Reduction
  • Effects of Rosiglitazone on Neointimal Hyperplasia After Coronary Stent Implantation in Patients with Diabetes Mellitus: A Serial Intravascular Ultrasound Study
  • Comparison of Co-Cr alloy ArthosPico Stent with Sirolimus-Eluting Stent for Simple De Novo Coronary Lesions
  • Efficacy of Sirolimus-Eluting Stent Implantation for Ostial Left Anterior Descending Artery Stenosis
  • Comparison of Early and Mid-term Outcomes After Sirolimus-Eluting Stent implantation Versus Coronary Artery Bypass Grafting in Patients with Multivessel Coronary Artery Disease
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent: Cypher Versus Taxus : LONG-DES
  • Identification of Patients at Low Risk of 6-Month Instent Restenosis of Bare Metal Stenting In the Real World
  • Glycosylated Hemoglobin Level as a Predictor of Restenosis After Drug-Eluting Stent Implantation in Diabetes Mellitus Patients
  • Tissue Plasminogen Activator on Admission is an Important Predictor for 30-day Mortality in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty
  • Serial Intravascular Ultrasound Findings in Patients with Ruptured
  • Coronary Plaques: Evidence of Both Plaque Stabilization and Lesion Progression
  • Evaluation of Neo-endothelization at the Stent Over Lapping Segment After Kissing Stenting with Sirolimis-Eluting Stent
  • Effects of Atorvastatin Versus Rosuvastatin Rherapy on Coronary Atherosclerotic Plaque: A Prospective Randomized Comparison Trial With Intravascular Ultrasound
  • Validation of New Drug-Eluting Stent in a Porcine Coronary Artery Model of Restenosis
  • Multicenter Study for Evaluating the Procedural Efficacy and Initial Safety of the TAXUS LiberteTM Paclitaxel-Eluting Stent in Coronary Lesions
  • Valsartan for Suppression of Plaque Volume and Restenosis After Paclitaxel-Eluting Stent
  • EuroSCORE as a Predictor of Death and Myocardial Infarction After Unprotected Left Main Coronary Stenting
  • Repeated Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting Stent Restenosis: Comparison with Conventional Therapies
  • Tritace PEP Study in Metabolic Syndrome
  • Comparison of the Efficacy of Zotarolimus(ABT 578)-Eluting Stent Versus Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Coronary Lesions: The Prospective, Randomized, and Multi-center Trial
  • Effects of Triple Antiplatelet Therapy on Platelet Function in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Stenting
  • To Evaluate the ‘Real World’ Clinical Performance of the Medtronic EndeavorTM ABT-578 Eluting Coronary Stent System : A Prospective, Multicenter Registry(E-Five Registry)
  • Premier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PhaseIII : Multicenter Trial: PRE-COMBAT Trial
  • A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients with Metabolic Syndrome and Hpercholesterolemia at High Risk for Coronary Heart Disease
  • Impact of Cilostazol on Neointimal Hyperplasia After ABT578-Eluting Stent Implantation in Patients with Long Coronary Lesions: Prospective, Double Blind, Randomized, and Multicenter trial
  • Focal Type In-Stent Restenosis After Drug-Eluting Stent Implantation Treated by Cutting Balloon Angioplasty Versus Sirolimus-Eluting Stent
  • Revascularization Treatment for Unprotected Left Main Coronary Artery Stenosis in Korea: Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Surgery “Left Main Registry in Korea”
  • Evaluation of the Long-Term Safety After Zotarolimus-Eluting Stent, Sirolimus-Eluting Stent, or PacliTaxel-Eluting Stent Implantation for Coronary Lesions-Late Coronary Arterial Thrombotic Events: The ZEST-LATE trial
  • Comparison Between Drug-Eluting Stents for the Treatment of the Diffuse Type In-Stent Restenosis After Drug-Eluting Stents Implantation: Sirolimus-Eluting vs. Paclitaxel-Eluting Stents (DES-ISR Trial)
  • The e-SELECT Registry A MultiCenter Post Market Surveillance
  • Preventive Strategies of REnal Insufficiency in Patients with Diabetes Undergoing InterVENTion or Arteriography: PREVENT Trial
  • Correlation of Clopidogrel Therapy Discontinuation in REAL-world Patients Treated with Drug-Eluting Stent Implantation and Late Coronary Arterial Thrombotic Events: REAL-LATE Trial
  • Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial Prospective, Multicenter, Randomized, Twoarm, Open-label Trial
  • Optimal Stenting Strategy for True Bifurcation Lesion
  • Choice of Optimal StRategy fOr Bifurcation LeSions with Normal Side Branch
  • Comparison of the Efficacy and Safety of PaclItaxel-Eluting CoroflexTM Please Stent Versus Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III: Sirolimus vs.Everlolimus-Eluting Stent
  • The BEST TRIAL Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease: Phase IV: Multicenter trial
  • Randomized Comparison of Everolimus- Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus (ESSENCE-DIABETES TRIAL)
  • A Randomized, Double-Blind, Single Center, Study of Effect of High-Dose(40mg) and Low-Dose(10mg) Statin for Coronary Plaque Modification
  • Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the Asian Population
  • Prospective Evaluation of Outcomes of Everolimus-Eluting Stent (XIENCE V) Implantation for Unprotected Left Main Coronary Artery Stenosis: Multicenter trial
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III: Sirolimus vs. Zotarolimus-Eluting Stent
  • Randomized Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients with DIABETES Mellitus
  • Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients with Chronic Total Occlusion
  • Effectiveness of Clopidogrel Resinate(PRegrelr) in Patients Undergoing Percutaneous Coronary Intervention compared with Clopidogrel Bisulfate(Plavix)
  • Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
  • New Aortic Valve Replacement in Selected High-Risk Patients with Aortic Stenosis without Conventional Sternotomy
  • Evaluation of Effectiveness and Safety of PROMUS Element™ in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of NOBORI stent in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of BIOMATRIX in Routine Clinical Practice; A Multicenter, PROSPECTIVE OBSERVATIONAL STUDY
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-V: Biolimus A9-Eluting (NOBORI) vs. Everolimus-eluting (PROMUS-ELEMENT) Stent
  • Comparison of Long-Term Angiographic Efficacy of Zotarolimus-Eluting Stent with Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for Coronary Lesions
  • A Global Multicenter, Prospective, Real World Observational Study for Left Main Disease Treatment
  • Triple Antiplatelet Therapy Significantly Reduces Ischemic Events After Drug-Eluting Stent Implantation; Drug-Eluting Stenting Followed by Cilostazol Treatment REduces Adverse Serious Cardiac Events (DECREASE-PCI Study)
  • Randomized Comparison of Dual Drug-Eluting Cilotax Stent and Everolimus- Eluting Stent Implantation for DE Novo Coronary Artery DisEase in Patients with DIABETES Mellitus
  • A Randomized, Double-Blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERed Coronary Disease
  • Effects of Fimasartan on Plaque Progression and Stability in a Rabbit Model of Atherosclerosis
  • Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-VI: Everolimus-eluting vs. Zotarolimus-Eluting Stents
  • Geometric Effect on Fractional Flow Reserve: Computational Flow Dynamics Study
  • Evaluation of Effectiveness and Safety of XIENCE PRIME™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
  • A Multicenter, Prospective Observational Cohort Study Of Effectiveness and Safety of RESOLUTE INTEGRITY for Patients with Complex Clinical and Lesion Subsets
  • Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale : DEFENSE-PFO trial
  • The Efficacy and Safety of Edwards SAPEN XT Implantation in High Surgical Risk Patients with Severe Aortic Stenosis: Prospective, Single Center Study
  • The Efficacy and Safety of Core valve Implantation in High Surgical Risk Patients with Severe Aortic Stenosis: Prospective, Single Center Study
  • Evaluation of Effectiveness and Safety of the GENOUS STENT in ST-Segment Elevation Myocardial Infarction
  • Effects of Fimasartan on Plaque Progression and Stability in a Rabbit Model of Atherosclerosis
  • PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -3 using Promus Element Everolimus-Eluting Coronary Stent System in Patients with Left Main Coronary Artery Disease
  • PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -3 using Resolute Integrity Zotarolimus-Eluting Coronary Stent System in Patients with Left Main Coronary Artery Disease
  • PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy -5 Orsiro™ Coronary Stent System in Patients with Left Main Coronary Artery Disease
  • A Multicenter, Real World Observational Study to Validate the Effectiveness and Safety of FFR guided PCI (IRIS-FFR Registry)
  • Evaluation of Effectiveness and Safety of Cilotax Stent in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
  • Treatment of Drug-Eluting Stent REstenosis Using Drug-Eluting STents vs. Drug-COated Balloon for Preventing REcurrent In-Stent Restenosis Asan Multivessel Registry - Prospective cohort, Retrospective cohort
  • Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort
  • Educational Contents & Exercise Program Development for Cardiac Rehabilitation Solutions and Verify Effectiveness
  • Evaluation of Effectiveness and Safety of Premier™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Orsiro™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of Desyne™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • Evaluation of Effectiveness and Safety of XIENCE XPEDITION™ in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
  • EARly Prevention of aTHeroma Progression(EARTH trial)
  • A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients with Acute Coronary Syndromes Intended for Invasive Management: TICAKOREA Trial
  • Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Implantation in the Asian Population (the Asian TAVR registry)
  • Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-luting Stent Implantation for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus: 5-Year clinical outcomes of ESSENCE DIABETES trial
  • The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis with Vulnerable Plaque Characteristics
Home About CVRF
Mission
Board Members
Management Team
CVRF Brochure
The Heart Beat
Research
Clinical Research Coordinating Center(CRCC)
- Data Management
- Core Laboratories
Translational Research
Research Activity
Paper Publication
Conference
TCTAP
AP VALVES
Complex PCI
Education
www.summitMD.com
Publication
ACT Program
Fellowship Training Program
- The Short-term Training Program
- The Long-term Training Program
- IVUS Fellowship Program
Fundraising
CVRF YoutubeFacebook